Oppenheimer logo banner header

Joint Bookrunner on Protara Therapeutics' Confidentially Marketed Public Offering

Oppenheimer & Co. Inc. acted as Joint Bookrunner on Protara Therapeutics’ Confidentially Marketed Public Offering of Approximately $100M